Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Prostatic Neoplasms 4Sexuality 2Sexual Dysfunction, Physiological 2Erectile Dysfunction 2Waldenstrom Macroglobulinemia 1Vascular Malformations 1Urogenital Neoplasms 1Solid Tumor 1Sarcoma 1Rectal Neoplasms 1Radiation Injuries 1Postoperative Complications 1Neurologic Manifestations 1Lymphatic Abnormalities 1Lymphangioma 1Infertility 1Glioma 1Glioblastoma 1Gastrointestinal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Bevacizumab 3Radiosurgery 2Irinotecan 2pembrolizumab 1Vorinostat 1Valproic Acid 1Thalidomide 1Temozolomide 1Surveys and Questionnaires 1Sorafenib 1Sildenafil Citrate 1Pliability 1Nivolumab 1Morphine 1Methadone 1Exercise 1Equipment and Supplies 1Eating 1Carboplatin 1Amifampridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neurologic Manifestations × Sildenafil Citrate × Clear all
NCT01817751 2024-07-17

Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma

Virginia Commonwealth University

Phase 2 Completed
47 enrolled 13 charts
CNS

Brain Neoplasms, Glioblastoma, Glioma, Neurologic Manifestations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡